Author:
Albrecht Katinka,Leipe Jan
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Albrecht K, Poddubnyy D, Leipe J, Sewerin P, Iking-Konert C, Scholz R, Krüger K (2022) Perioperative management of treatment of patients with inflammatory rheumatic diseases: updated recommendations of the German Society of Rheumatology. Z Rheumatol 81:212–224. https://doi.org/10.1007/s00393-021-01140-x
2. Premkumar A, Morse K, Levack AE, Bostrom MP, Carli AV (2018) Periprosthetic joint infection in patients with inflammatory joint disease: prevention and diagnosis. Curr Rheumatol Rep 20(11):68. https://doi.org/10.1007/s11926-018-0777-6
3. Bissar L, Almoallim H, Albazli K, Alotaibi M, Alwafi S (2013) Perioperative management of patients with rheumatic diseases. Open Rheumatol J 7:42–50. https://doi.org/10.2174/1874312901307010042
4. den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, de Waal-Malefijt M, van den Hoogen FH (2007) Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 34(4):689–695
5. George MD, Baker JF, Winthrop K, Curtis JR (2019) Risk of biologics and glucocorticoids in patients with rheumatoid arthritis undergoing arthroplasty. Ann Intern Med 171(9):680. https://doi.org/10.7326/L19-0528